MARTA BODNARUK: Open Payments
NPI 1780356279 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$669 in 6 payments from 4 companies in 2025. Trend: 2023 $490 · 2024 $385 · 2025 $669
Food & beverage: $669
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 3 | $290 |
| Daiichi Sankyo Inc. | 1 | $150 |
| Incyte Corporation | 1 | $124 |
| AstraZeneca Pharmaceuticals LP | 1 | $106 |
Products named: Enhertu, Jakafi, Trodelvy.
Industry payments across CA — which companies pay providers there.
